AKR7L
gene geneOn this page
Also known as AFAR3
Summary
AKR7L (aldo-keto reductase family 7 like (gene/pseudogene), HGNC:24056) is a protein-coding gene on chromosome 1p36.13, encoding Aflatoxin B1 aldehyde reductase member 4 (Q8NHP1). Can reduce the dialdehyde protein-binding form of aflatoxin B1 (AFB1) to the non-binding AFB1 dialcohol.
This gene is one of three aldo-keto reductase genes that are present in a cluster on the p arm of chromosome 1. The encoded proteins are involved in the reduction of the dialdehyde protein-binding form of aflatoxin B1 (AFB1) to the non-binding AFB1 dialcohol. It has been speculated that this family member encodes a selenoprotein, which includes a selenocysteine (Sec) residue in lieu of a UGA translational termination codon. However, there is no evidence that such a protein is produced in vivo. The alternative interpretation is that this family member is a segregating pseudogene, where some individuals have an allele that encodes a functional enzyme, while other individuals have an allele encoding a protein that is predicted to be non-functional.
Source: NCBI Gene 246181 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 6 total — 1 pathogenic
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:24056 |
| Approved symbol | AKR7L |
| Name | aldo-keto reductase family 7 like (gene/pseudogene) |
| Location | 1p36.13 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | AFAR3 |
| Ensembl gene | ENSG00000211454 |
| Ensembl biotype | protein_coding |
| OMIM | 608478 |
| Entrez | 246181 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 2 protein_coding_LoF, 1 retained_intron
ENST00000429712, ENST00000457194, ENST00000493176
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000429712 — 7 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001504261 | 19269272 | 19269371 |
| ENSE00001627290 | 19269583 | 19269679 |
| ENSE00001719156 | 19273861 | 19274194 |
| ENSE00001755337 | 19267103 | 19267461 |
| ENSE00003476553 | 19270748 | 19270935 |
| ENSE00003675263 | 19268572 | 19268701 |
| ENSE00003715904 | 19270451 | 19270555 |
Expression profiles
Bgee: expression breadth ubiquitous, 132 present calls, max score 95.35.
Top tissues by expression
134 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| duodenum | UBERON:0002114 | 95.35 | gold quality |
| right lobe of liver | UBERON:0001114 | 93.11 | gold quality |
| liver | UBERON:0002107 | 90.53 | gold quality |
| body of pancreas | UBERON:0001150 | 87.45 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 85.43 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 85.17 | gold quality |
| body of stomach | UBERON:0001161 | 84.93 | gold quality |
| small intestine | UBERON:0002108 | 84.57 | gold quality |
| stomach | UBERON:0000945 | 82.00 | gold quality |
| fundus of stomach | UBERON:0001160 | 81.52 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 79.64 | gold quality |
| transverse colon | UBERON:0001157 | 78.52 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 78.37 | gold quality |
| cortex of kidney | UBERON:0001225 | 76.91 | gold quality |
| pancreas | UBERON:0001264 | 76.78 | gold quality |
| metanephros cortex | UBERON:0010533 | 76.44 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 76.01 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 74.77 | gold quality |
| kidney | UBERON:0002113 | 74.76 | gold quality |
| cerebellar cortex | UBERON:0002129 | 74.70 | gold quality |
| cerebellum | UBERON:0002037 | 74.66 | gold quality |
| intestine | UBERON:0000160 | 74.14 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 73.94 | gold quality |
| rectum | UBERON:0001052 | 73.46 | gold quality |
| gall bladder | UBERON:0002110 | 72.69 | gold quality |
| mucosa of stomach | UBERON:0001199 | 72.06 | gold quality |
| colon | UBERON:0001155 | 70.49 | gold quality |
| skin of leg | UBERON:0001511 | 66.98 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 66.92 | gold quality |
| nucleus accumbens | UBERON:0001882 | 66.59 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 5.24 |
Regulation
Is transcription factor: no
Cross-species orthologs
12 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | akr7a3 | ENSDARG00000016649 |
| mus_musculus | Akr7a5 | ENSMUSG00000028743 |
| rattus_norvegicus | Akr7a2 | ENSRNOG00000017780 |
| drosophila_melanogaster | CG6083 | FBGN0036183 |
| drosophila_melanogaster | CG18547 | FBGN0037973 |
| drosophila_melanogaster | CG3397 | FBGN0037975 |
| caenorhabditis_elegans | WBGENE00003176 | |
| caenorhabditis_elegans | WBGENE00009980 | |
| caenorhabditis_elegans | WBGENE00009981 | |
| caenorhabditis_elegans | WBGENE00012722 | |
| caenorhabditis_elegans | WBGENE00012723 | |
| caenorhabditis_elegans | WBGENE00015307 |
Paralogs (16): AKR7A2 (ENSG00000053371), KCNAB2 (ENSG00000069424), AKR1B1 (ENSG00000085662), AKR1A1 (ENSG00000117448), AKR1D1 (ENSG00000122787), AKR1C2 (ENSG00000151632), AKR7A3 (ENSG00000162482), AKR1E2 (ENSG00000165568), KCNAB1 (ENSG00000169282), KCNAB3 (ENSG00000170049), AKR1C1 (ENSG00000187134), AKR1C3 (ENSG00000196139), AKR1B10 (ENSG00000198074), AKR1C4 (ENSG00000198610), AKR1B15 (ENSG00000227471), AKR1C8 (ENSG00000264006)
Protein
Protein identifiers
Aflatoxin B1 aldehyde reductase member 4 — Q8NHP1 (reviewed: Q8NHP1)
Alternative names: AFB1 aldehyde reductase 3, Aldoketoreductase 7-like
All UniProt accessions (0):
UniProt curated annotations — full annotation on UniProt →
Function. Can reduce the dialdehyde protein-binding form of aflatoxin B1 (AFB1) to the non-binding AFB1 dialcohol. May be involved in protection of liver against the toxic and carcinogenic effects of AFB1, a potent hepatocarcinogen.
Tissue specificity. Mainly expressed in uterus.
Polymorphism. The sequence shown in this entry differs from the translation of the reference genome assembly (GRCh38/hg38) due to a nonsense variant creating stop codon at position 106 in the reference genome. This sequence carries a selenocysteine-insertion element (SECIS)-like structure that during translation may recode an in-frame TGA-stop codon to a selenocysteine. However, there is no evidence that such a protein is produced in vivo. The sequence shown in this entry is that of variant p.Ter106Arg. This variant has a frequency of about 3% in the human population according to the Genome Aggregation Database (gnomAD v3.1.2).
Similarity. Belongs to the aldo/keto reductase family. Aldo/keto reductase 2 subfamily.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q8NHP1-1 | 1 | yes |
| Q8NHP1-3 | 2 |
RefSeq proteins (0): (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR023210 | NADP_OxRdtase_dom | Domain |
| IPR036812 | NAD(P)_OxRdtase_dom_sf | Homologous_superfamily |
| IPR050523 | AKR_Detox_Biosynth | Family |
Pfam: PF00248
UniProt features (17 total): binding site 8, sequence variant 3, chain 1, active site 1, site 1, modified residue 1, splice variant 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8NHP1-F1 | 95.89 | 0.95 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Catalytic / active sites (2): 49 (proton donor); 77 (lowers pka of active site tyr)
Ligand- & substrate-binding residues (8): 44; 113; 143–144; 169; 198–208; 222; 232; 290–298
Post-translational modifications (1): 85
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-5423646 | Aflatoxin activation and detoxification |
MSigDB gene sets: 17 (showing top):
REACTOME_BIOLOGICAL_OXIDATIONS, WCTCNATGGY_UNKNOWN, GATA1_01, GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_CH_OH_GROUP_OF_DONORS, chr1p36, GOMF_ALCOHOL_DEHYDROGENASE_NADPPLUS_ACTIVITY, REACTOME_AFLATOXIN_ACTIVATION_AND_DETOXIFICATION, GOMF_ALCOHOL_DEHYDROGENASE_NAD_P_PLUS_ACTIVITY, GOMF_OXIDOREDUCTASE_ACTIVITY, MEBARKI_HCC_PROGENITOR_FZD8CRD_DN, BUSSLINGER_GASTRIC_PARIETAL_CELLS, BUSSLINGER_DUODENAL_LATE_IMMATURE_ENTEROCYTES, DESCARTES_FETAL_PANCREAS_ACINAR_CELLS, E2F_Q2, CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_DN
GO Biological Process (0):
GO Molecular Function (2): oxidoreductase activity (GO:0016491), alcohol dehydrogenase (NADP+) activity (GO:0008106)
GO Cellular Component (6): cytoplasm (GO:0005737), cytosol (GO:0005829), extracellular exosome (GO:0070062), nuclear envelope (GO:0005635), smooth endoplasmic reticulum (GO:0005790), Golgi apparatus (GO:0005794)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Biological oxidations | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 2 |
| cytoplasm | 2 |
| endomembrane system | 2 |
| catalytic activity | 1 |
| alcohol dehydrogenase [NAD(P)+] activity | 1 |
| intracellular anatomical structure | 1 |
| extracellular vesicle | 1 |
| nucleus | 1 |
| organelle envelope | 1 |
| endoplasmic reticulum | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
0 interactions, top by confidence (×1000):
IntAct
10 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| PEF1 | PDCD6 | psi-mi:“MI:0914”(association) | 0.900 |
| AKR7A3 | AKR7A2 | psi-mi:“MI:0914”(association) | 0.890 |
| AKR7A3 | ASAH1 | psi-mi:“MI:0914”(association) | 0.530 |
| SCRIB | CHD2 | psi-mi:“MI:0914”(association) | 0.350 |
| AKR7L | KIF2A | psi-mi:“MI:0914”(association) | 0.350 |
| AKR7A2 | DCTN6 | psi-mi:“MI:0914”(association) | 0.350 |
| KCTD13 | SMTN | psi-mi:“MI:0914”(association) | 0.350 |
ESM2 similar proteins: A1YER2, A1YFX9, A2T7G9, A6NNS2, B0BN93, B0BNF8, O22718, O35331, O35678, O75911, O77769, O80526, O88876, O95154, P11172, P14755, P15904, P84169, Q06136, Q15738, Q1RMJ5, Q28DS0, Q2KIJ5, Q2QNG7, Q2QZ86, Q3SZM9, Q3T067, Q3ZBE9, Q5E964, Q5I0K3, Q5PPL3, Q5R514, Q5R5C9, Q5RDZ2, Q6AY30, Q6UWP2, Q811X6, Q86WA6, Q8JGT5, Q8K183
Diamond homologs: A0A0F7TN16, A0A0U5GHU6, A0A5B8YXI2, C7ZBE5, C8VQ93, M2YJQ2, M2YMU7, O43488, O95154, P25612, P38918, P42884, P43546, P43547, P47182, Q00049, Q00258, Q00727, Q01333, Q01752, Q07747, Q08361, Q6Q875, Q6UEH5, Q75ZG2, Q75ZG3, Q8CG45, Q8CG76, Q8NHP1, A0A3B1EFQ1, A0QJ99, A2XRZ0, A2XRZ6, B8ASB2, C6TBN2, F4HPY8, K3VD70, O14125, O14295, O22707
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
6 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 1228381 | GRCh37/hg19 1p36.13-36.12(chr1:16785250-23491592)x1 | Pathogenic |
SpliceAI
989 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:19267458:CACC:C | acceptor_gain | 1.0000 |
| 1:19267460:CC:C | acceptor_gain | 1.0000 |
| 1:19267461:CC:C | acceptor_gain | 1.0000 |
| 1:19267462:C:CC | acceptor_gain | 1.0000 |
| 1:19268697:AGAAG:A | acceptor_gain | 1.0000 |
| 1:19268698:GAAG:G | acceptor_gain | 1.0000 |
| 1:19268699:AAG:A | acceptor_gain | 1.0000 |
| 1:19268700:AG:A | acceptor_gain | 1.0000 |
| 1:19268701:GCTG:G | acceptor_loss | 1.0000 |
| 1:19268702:C:CC | acceptor_gain | 1.0000 |
| 1:19268703:T:G | acceptor_loss | 1.0000 |
| 1:19268707:C:CT | acceptor_gain | 1.0000 |
| 1:19268708:A:T | acceptor_gain | 1.0000 |
| 1:19268709:G:C | acceptor_gain | 1.0000 |
| 1:19268709:G:GC | acceptor_gain | 1.0000 |
| 1:19268715:A:AC | acceptor_gain | 1.0000 |
| 1:19269270:A:AC | donor_gain | 1.0000 |
| 1:19269271:C:CT | donor_gain | 1.0000 |
| 1:19269274:ATT:A | donor_gain | 1.0000 |
| 1:19269276:T:TA | donor_gain | 1.0000 |
| 1:19269294:A:AC | donor_gain | 1.0000 |
| 1:19269295:C:CC | donor_gain | 1.0000 |
| 1:19269581:ACCAG:A | donor_gain | 1.0000 |
| 1:19269582:CCAGC:C | donor_gain | 1.0000 |
| 1:19269676:TGCC:T | acceptor_gain | 1.0000 |
| 1:19269678:CC:C | acceptor_gain | 1.0000 |
| 1:19269679:CC:C | acceptor_gain | 1.0000 |
| 1:19269680:C:CA | acceptor_loss | 1.0000 |
| 1:19269680:C:CC | acceptor_gain | 1.0000 |
| 1:19269681:T:C | acceptor_loss | 1.0000 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000526528 (1:19273545 A>G), RS1001293736 (1:19273736 G>A,C,T), RS1001857246 (1:19269182 G>A), RS1002788470 (1:19266584 G>T), RS1002902932 (1:19266317 G>GTTTA,GTTTC), RS1003525686 (1:19275205 G>A), RS1003850561 (1:19265732 G>C,T), RS1005015505 (1:19265696 T>G), RS1005646816 (1:19272952 C>G,T), RS1005861520 (1:19271920 A>G), RS1006026288 (1:19267014 A>G), RS1006102320 (1:19268301 G>C), RS1006549563 (1:19266643 A>G), RS1007659974 (1:19272218 C>A), RS1008383430 (1:19274447 C>A,G,T)
Disease associations
OMIM: gene MIM:608478 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST000597_10 | Brain structure | 1.000000e-07 |
| GCST007001_1 | Cerebrospinal AB1-42 levels in normal cognition | 5.000000e-07 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004670 | beta-amyloid 1-42 measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
11 total (human), top 11 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | affects methylation, decreases expression | 2 |
| aristolochic acid I | increases expression | 1 |
| sodium arsenite | increases expression | 1 |
| butyraldehyde | decreases expression | 1 |
| perfluorooctane sulfonic acid | decreases expression | 1 |
| fipronil | affects cotreatment, decreases expression | 1 |
| DEET | affects cotreatment, decreases expression | 1 |
| Xylitol | increases expression | 1 |
| Oleic Acid | decreases expression | 1 |
| Okadaic Acid | decreases expression | 1 |
| S-Nitrosoglutathione | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.